DE2638716A1 - Antihypertensiva - Google Patents

Antihypertensiva

Info

Publication number
DE2638716A1
DE2638716A1 DE19762638716 DE2638716A DE2638716A1 DE 2638716 A1 DE2638716 A1 DE 2638716A1 DE 19762638716 DE19762638716 DE 19762638716 DE 2638716 A DE2638716 A DE 2638716A DE 2638716 A1 DE2638716 A1 DE 2638716A1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
preparation according
dosage
hydrochloride
hydrochlorothiazide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19762638716
Other languages
German (de)
English (en)
Inventor
Auf Nichtnennung Antrag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm Pharma GmbH
Deutsche ICI GmbH
Original Assignee
Roehm Pharma GmbH
Deutsche ICI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma GmbH, Deutsche ICI GmbH filed Critical Roehm Pharma GmbH
Priority to DE19762638716 priority Critical patent/DE2638716A1/de
Priority to DE19762660861 priority patent/DE2660861C2/de
Priority to FR7725671A priority patent/FR2362636A1/fr
Priority to GB35524/77A priority patent/GB1584089A/en
Priority to JP10249477A priority patent/JPS5350340A/ja
Publication of DE2638716A1 publication Critical patent/DE2638716A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19762638716 1976-08-27 1976-08-27 Antihypertensiva Ceased DE2638716A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19762638716 DE2638716A1 (de) 1976-08-27 1976-08-27 Antihypertensiva
DE19762660861 DE2660861C2 (ja) 1976-08-27 1976-08-27
FR7725671A FR2362636A1 (fr) 1976-08-27 1977-08-23 Composition therapeutique pour le traitement des etats d'hypertension
GB35524/77A GB1584089A (en) 1976-08-27 1977-08-24 Antihypertensive pharmaceutical compositions
JP10249477A JPS5350340A (en) 1976-08-27 1977-08-26 Medicine having blood pressure depressing effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762638716 DE2638716A1 (de) 1976-08-27 1976-08-27 Antihypertensiva

Publications (1)

Publication Number Publication Date
DE2638716A1 true DE2638716A1 (de) 1978-03-02

Family

ID=5986558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762638716 Ceased DE2638716A1 (de) 1976-08-27 1976-08-27 Antihypertensiva

Country Status (4)

Country Link
JP (1) JPS5350340A (ja)
DE (1) DE2638716A1 (ja)
FR (1) FR2362636A1 (ja)
GB (1) GB1584089A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039388A2 (de) * 1980-05-02 1981-11-11 Röhm Pharma GmbH Diagnostisches Verfahren zur Bestimmung der Leberfunktion
EP0043548A1 (de) * 1980-07-04 1982-01-13 Hoechst Aktiengesellschaft Salz aus Furosemid oder Piretanid als Säurekomponente und Penbutolol als Basenkomponente sowie Arzneimittel, das beide Komponenten enthält

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions
EP0081006B1 (en) * 1981-12-08 1985-09-25 Smithkline Beckman Corporation Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417864A (en) 1971-12-10 1975-12-17 Sandoz Ltd Antihyertensive compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417864A (en) 1971-12-10 1975-12-17 Sandoz Ltd Antihyertensive compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H. Hornbostel et al., Innere Medizin in Praxis und Klinik, Bd.II, S.6-15 bis 6-19

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039388A2 (de) * 1980-05-02 1981-11-11 Röhm Pharma GmbH Diagnostisches Verfahren zur Bestimmung der Leberfunktion
EP0039388A3 (de) * 1980-05-02 1982-10-06 Röhm Pharma GmbH Diagnostisches Verfahren zur Bestimmung der Leberfunktion
EP0043548A1 (de) * 1980-07-04 1982-01-13 Hoechst Aktiengesellschaft Salz aus Furosemid oder Piretanid als Säurekomponente und Penbutolol als Basenkomponente sowie Arzneimittel, das beide Komponenten enthält
US4564625A (en) * 1980-07-04 1986-01-14 Hoechst Aktiengesellschaft Binary compositions of penbutolol and furosemide or piretanide

Also Published As

Publication number Publication date
FR2362636A1 (fr) 1978-03-24
GB1584089A (en) 1981-02-04
JPS5350340A (en) 1978-05-08
FR2362636B1 (ja) 1980-12-05

Similar Documents

Publication Publication Date Title
DE2856393C2 (de) Arzneimittel zur Behandlung von Morbus Parkinson
US4757072A (en) Carcinostatic agent
EP0864327B1 (de) Verwendung von Pyrimidinderivaten zur Herstellung eines Arzneimittels zur Prävention von Krebs
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
EP0752246A2 (de) Kappa-Opiate für entzündliche Darmerkrankungen
EP0607776A2 (de) Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha
DE2638716A1 (de) Antihypertensiva
EP0607777A2 (de) Verwendung von Leflunomid zur Herstellung von Interleukin 8
DE3739779A1 (de) Pharmazeutische praeparate
DE2658500C2 (de) Pharmazeutische Präparate mit kardioprotektiver Wirkung
DE2660861C2 (ja)
DE3141970C2 (ja)
EP1137438A1 (de) Zubereitung mit verbesserter therapeutischer breite, enthaltend nukleotidsyntheseinhibitoren
EP1919483B1 (de) Kombinationspräparat aus einem thiaziddiuretikum und einem schleifendiuretikum
DE3419425C2 (ja)
DE2437272C3 (de) 6-Trifluormethyl-2H-1,2,4-benzothiadiazin-1,1-dioxyde und sie enthaltende Arzneimittelzubereitungen
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
WO2002007713A2 (de) Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten
EP0508511B1 (de) Erzeugnisse, enthaltend Verapamil und Trandolapril
DE3213579C2 (ja)
DE10138538C2 (de) Tumorhemmende Lanthanverbindungen
DE3532036A1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks
EP1474134B1 (de) Kombinationspräparat des natrium-wasserstoff-austausch-inhibitors cariporide mit ramipril zur verhinderung bzw zur hemmung der herzinsuffizienz
DE3908232C2 (de) Verwendung von Verapamil zur Behandlung der Schlaf-Apnoe
DE2823267A1 (de) Antihypertensive praeparate

Legal Events

Date Code Title Description
OD Request for examination
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2660861

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2660861

8131 Rejection
AH Division in

Ref country code: DE

Ref document number: 2660861

Format of ref document f/p: P